Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2685-2692

  Jiang, Xian P ^a   Wang, Fen ^a   Yang, Ding C ^a   Elliott, Robert L ^a   Head, Jonathan F ^a  

^a The Mastology Research Institute   (United States)

Author keywords

Apoptosis; Breast cancer; Human; Iron; Mammary neoplasms; Rat

Indexed keywords

ACRIDINE ORANGE; DEFEROXAMINE MESYLATE; DNA FRAGMENT; ETHIDIUM BROMIDE; FERRIC CHLORIDE; GALLIUM; INDIUM; IRON CHELATE; PROTEIN BAX; PROTEIN BCL 2; RECEPTOR ANTIBODY; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER INHIBITION; CELL LABELING; CELL STRAIN MCF 7; CHROMATIN CONDENSATION; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; IRON CHELATION; IRON DEPLETION; IRON METABOLISM; IRON RESTRICTION; ISOTOPE LABELING; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STUDENT T TEST;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; DEFEROXAMINE; FEMALE; GALLIUM; HUMANS; INDIUM; IRON; IRON CHELATING AGENTS; MAMMARY NEOPLASMS, EXPERIMENTAL; ORGANOMETALLIC COMPOUNDS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, INBRED F344; TRANSFERRIN; TUMOR CELLS, CULTURED;

EID: 0036765987     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Brittenham GM: Disorders of iron metabolism: Iron deficiency and overload. In: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ (eds) Hematology-Basic Principles and Practice. Churchill Livingstone, New York, 1991, p. 327.
2. Cory JG: Role of ribonucleotide reductase in cell division. In: Cory JG, Cory AH (eds) Inhibitors of Ribonucleotide Diphosphate Reductase Activity. Pergamon Press, New York, 1989, p. 1.
3. Head JF, Wang F and Elliott RL: Antineoplastic drugs that interfere with iron metabolism in cancer cells. Advan Enzyme Regul 37: 147-169, 1997.
4. Hoyes KP, Hider RC and Porter JB: Cell cycle synchronization and growth inhibition by 3-hydroxypyridin-4-one iron chelators, in leukemia cell lines. Cancer Res 52: 4591-4599, 1992.
5. Taetle R, Castognola J and Mendelsohn J: Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies. Cancer Res 46: 1759-1763, 1986.
6. Wang F, Hailey K, Ward K, Elliott RL and Head JF: Growth inhibition of rat 13762NF mammary adenocarinoma by deferoxamine mesylate. Proc Am Assoc Cancer Res 35: 2420a, 1994.
7. Wang F, Elliott RL and Head JF: Inhibitory effect or deferoxamine mesylate and low iron diet on the 13762 NF rat mammary adenocarcinoma. Anticancer Res 19: 445-450, 1999.
8. Wyllie AK Morris RG, Smith AL and Dunlop D: Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macronuclear synthesis. J Path 142: 67-77, 1984.
9. Arend MJ, Morris RG and Wyllie AH: Apoptosis: the role of endonuclease. Am J Path 136: 599-608, 1990.
10. Allsopp TE, Wyatt S, Paterson FIF and Davies AM: The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell 73: 295-307, 1993.
11. Fisher TC, Milner AE, Gregory CD, Jachman AZ, Wynne-Aherne G, Hartley JA, Dive CD and Hickman JA: Bcl-2 modulation apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53: 3321-3327, 1993.
12. Mikhai V, Blagosklonny, Schulte T, Nguyen P, Trepel J and Neckers LM: Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res 56: 1851-1854, 1996.
13. Ando T, Shibata K, Suzuki T, Kurihara I, Hayashi K, Hayashi M, Saito I, Kawabe H, Tsujioka M and Saruta T: The possible role of apoptosis-suppressing genes, bcl-2 and mcl-1/EAT in human adrenal tumors. Endocr Res 24:955-960, 1998.
14. Novelli F, Allione A, Wells V, Forni G and Mallucci L: Negative cell cycle control of human T cells by beta-galactoside binding protein (beta GBP): induction of programmed cell death in leukemic cells. J Cell Physiol 178: 102-108, 1999.
15. Oltvai ZN, Milliman CL and Korsmeyer SK: Bcl-2, heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 74: 609-619, 1993.
16. Haq RU, Wereley JP and Chitambar CR: Induction of apoptosis by iron deprivation in human leukemic CCRF-CFM cells. Exp Hematol 23: 428-432, 1995.
17. Fukuchi K, Tomoyasu S, Tsuruoka N and Gomi K: Iron deprivation-induced apoptosis in HL- 60 cells. FEBS Lett 350: 139-142, 1994.
18. Hileti D, Panayiotidis P and Hoffbrand AV: Iron chelators induce apoptosis in proliferating cells. Br J Haematology 89: 181-187, 1995.
19. Leardi A, Caraglia M, Selleri C, Pepe S, Pizzi C, Notaro F, Fabbrocini A, De Lorenzo S, Musico M, Abbruzzese A, Bianco AR and Tagliaferri P: Desferioxamine increases iron depletion and apoptosis induced by ara-C of human myeloid leukaemic cells. Br J Haematol 102: 746-752, 1998.
20. Duke RC and Cohen JJ: Morphological and biochemical assays of apoptosis: quantitation of apoptotic index and cell viability using fluorescent dyes. In: Coligan JE, Kruisbeek AM, Margulies DK Shevach EM and Strober W (eds). Current Protocols in Immunology. John Wiley & Sons, 1992, pp. 3.17.1-3.
21. Duke RC and Cohen JJ: Morphological and biochemical assays of apoptosis: quantitation of DNA fragmentation in cells containing radiolabeled DNA. In: Coligan JE, Kruisbeek AM, Margulies DK Shevach EM and Strober W (eds) Current Protocols in Immunology. John Wiley & Sons, 1992, pp. 3.17.4-5.
22. Gavrieli Y, Sherman Y and Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501, 1992.
23. Gorczyca W, Gong J and Darzynkiewice Z: Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 53: 1945-1951, 1993.
24. 1 breast cancer. Clin Cancer Res 2: 1887-1894, 1996.
25. Becton DL and Roberts B: Antileukemic effects of deferoxamine on human myeloid leukemia cell lines. Cancer Res 49: 4809-4812, 1989.
26. Wang F, Head JF and Elliott RL: The up-regulation of transferrin receptors by deferoxamine enhance the growth inhibitory effect of gallium-transferrin on MCF-7 cells. Proc Am Assoc Cancer Res 37: 3423 a, 1996.
27. Chitambar CR and Seligman PA: Effects of different transferrin forms on transferrin receptor expression, iron uptake and cellular proliferation of human leukemic BL60 cells: mechanisms responsible for the specific cytotoxicity of transferrin-gallium. J Clin Invest 78: 1538-1546, 1986.
28. Donfrancesco A, Deb G, Dominici C, Pileggi D, Castello MA and Helson L: Effects of a single course of deferoxamine in neuroblastoma patients. Cancer Res 50: 4929-4930, 1990.
29. Weick K, Stephens RL, Baker LH and Jones SE: Gallium nitrate in malignant lymphoma: a Southern Oncology Group Study. Cancer Treat Rep 67: 823-825, 1983.
30. Seidman AD, Scher HI, Heinemann MN, BaJorin DF, Sternberg CN, Dershaw DD, Silverberg M and Bosl GJ: Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumor. Cancer 68: 2561-2565, 1991.
31. Keberle H: The biochemistry of deferrioxamine and its relation to iron metabolism. Ann NY Acad Sci 119: 758-768, 1964.
32. Constan AA, Benjamin SA, Tessari JD, Baker DC and Yang RS: 1995 STP Young Investigators Award Recipient. Increased rate of apoptosis correlates with hepatocellular proliferation in Fischer-344 rats following long-term exposure to a mixture of ground water contaminants. Toxicol Pathol 24: 315-322, 1996.
33. Fukuchi & Tomoyasu S, Watanabe H and Kaetsu S: Iron deprivation results in an increase in p53 expression. Biol Chem Hoppe Seyler 376: 627-630, 1995.
34. Merlo GR, Cella N and Hynes NE: Apoptosis is accompanied by changes in bcl-2 and bax expression, induced by loss of attachment, and inhibited by specific extracellular matrix protein in mammary epithelial cells. Cell Growth Differentiation 8: 251-260, 1997.
35. Steller H: Mechanisms and genes of cellular suicide. Science 267: 1445-1449, 1995.
36. Chittenden T, Harrington EA, O'Connor R, Flen-dngton C, Lutz R, Even GI and Guild BC: Induction of apoptosis by the bcl-2 homologue Bak. Nature 374: 733-736, 1995.
37. Yang E, Zha J, Jockel J, Boise LK Thompson CB and Korsmeyer SJ: Bad, a heterodimeric partner for bcl-M and bcl-2 displaces Bax and promotes cell death. Cell 80: 285-291, 1995.